Home / Companies / Be Biopharma / Trends
Be Biopharma H-1B trends
Quarterly LCA aggregate trend points for Be Biopharma. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Be Biopharma span 2021 Q4 to 2025 Q3, peaking at 3 filings in 2024 Q3.
The most recent reported period (2025 Q3) shows 2 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2021 Q4 | 2 | 2 | 1 | $180,000 | $135,990 | 1 | 50.0% |
| 2022 Q1 | 1 | 1 | 1 | $95,000 | $71,822 | 1 | 100.0% |
| 2022 Q2 | 1 | 1 | 1 | $100,000 | $84,448 | 1 | 100.0% |
| 2022 Q3 | 1 | 1 | 1 | $85,000 | $58,677 | 1 | 100.0% |
| 2022 Q4 | 1 | 1 | 1 | $155,000 | $86,549 | 1 | 100.0% |
| 2023 Q3 | 2 | 2 | 2 | $91,547 | $79,518 | 2 | 100.0% |
| 2023 Q4 | 1 | 1 | 1 | $123,000 | $91,374 | 1 | 100.0% |
| 2024 Q3 | 3 | 3 | 2 | $97,590 | $87,367 | 3 | 100.0% |
| 2024 Q4 | 3 | 3 | 3 | $156,226 | $99,632 | 3 | 100.0% |
| 2025 Q2 | 1 | 1 | 1 | $160,000 | $141,086 | 1 | 100.0% |
| 2025 Q3 | 2 | 2 | 2 | $101,400 | $88,296 | 2 | 100.0% |
Frequently asked questions
- How have H-1B filings for Be Biopharma changed over time?
- H-1B LCA filings for Be Biopharma span 2021 Q4 to 2025 Q3, peaking at 3 filings in 2024 Q3. The most recent reported period (2025 Q3) shows 2 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=be+biopharma&metric=lca_countJSON